<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT2015022521195N2</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2015-06-29</date_registration>
      <primary_sponsor>Shiraz University of Medical Sciences, International Branch</primary_sponsor>
      <public_title>The effectiveness of systematic tinidazole in the treatment of periodontitis in smokers</public_title>
      <acronym></acronym>
      <scientific_title>Assessing the effectiveness of systemic Tinidazole as an adjunct to non-surgical periodontal therapy in the treatment of chronic periodontitis in smokers</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2014-12-22</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>60</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/18637</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Other design features: Participants in the test group received 2g tinidazole as loading dose in the first day and then  Participants in the test group&#13;
received 500 mg tinidazole to be taken once daily for 6 days. Participants in the control group received&#13;
similar looking placebos prepared at the College of Pharmacy ,shiraz. The treatment group was masked from the patient, clinical examiner, operator, and statistician.&#13;
Student’s t test was the statistical test used for comparing differences in PI, BI,GI, PD, Recession and CAL between the two groups .To compare the differences in various parameters&#13;
within each group, paired t test was used. The level of significance (a) was taken as 0.05, and the confidence intervals (CIs) were set at 95%. P &lt;0.05 was taken as statistically significant.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Moderate to advanced periodontitis in smokers.</hc_freetext>
      <i_freetext>Intervention 1: In the control proup after measuring the indexes and doing SRP we give placebo to the patiants ,for the first day 4 tablets then thy use 1 tablet per day for 6 days. Intervention 2: Participants in the intervention group received 2g tinidazole as loading dose in the first day and then  Participants in the test groupreceived 500 mg tinidazole to be taken once daily for 6 days.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan></results_IPD_plan>
      <results_IPD_description></results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Armaghan Tarjan</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Nader Kazemi clinic, Valiasr square</address>
        <city>Shiraz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>71546-14111</zip>
        <telephone>+98 71 3229 7390</telephone>
        <email>armaghant70@yahoo.com; tarjan@sums.ac.ir</email>
        <affiliation>Shiraz University of Medical Sciences, International Branch</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Dr. Farin Kiany</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Dentistry department, Ghom abad</address>
        <city>Shiraz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>71956-15878</zip>
        <telephone>+98 71 3626 3193</telephone>
        <email>farinkiany@yahoo.com</email>
        <affiliation>Dentistry Department, Shiraz University of Medical Sciences, International Branch</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>sixty systemically healthy individuals with untreated moderate-to-advanced periodontitis were&#13;
recruited into the study based on the following criteria:&#13;
1)patients do not use antibiotics in last 2 months.&#13;
2)do not have periodontal disease in last 6 months.&#13;
3)do not have systematic disease including: diabetes, hypertension, heart disease and other infectious diseases&#13;
4)participants should be current smokers(are defined as persons who had smoked at least 100 cigarettes in their lifetime and reported that they were smoking at the time of interview.&#13;
 Exclusion criteria: 1) pregnancy or lactation; 2) systemic diseases (such as diabetes&#13;
mellitus); 3) systemic antibiotics taken within the previous 2 months; 4) use of non-steroidal&#13;
anti-inflammatory drugs; 5) confirmed or suspected intolerance to 5-nitroimidazole derivatives; and 6)&#13;
subgingival SRP or surgical periodontal therapy in the previous 6 month.</inclusion_criteria>
      <agemin>no limit</agemin>
      <agemax>no limit</agemax>
      <gender>Both</gender>
      <exclusion_criteria></exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>XXI</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Factors influencing health status and contact with health services</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Placebo</i_code>
      <i_code>Treatment - Drugs</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>In the control proup after measuring the indexes and doing SRP we give placebo to the patiants ,for the first day 4 tablets then thy use 1 tablet per day for 6 days</i_keyword>
      <i_keyword>Participants in the intervention group received 2g tinidazole as loading dose in the first day and then  Participants in the test groupreceived 500 mg tinidazole to be taken once daily for 6 days..</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>GI Leo and Silness was measured. Timepoint: Baseline visit and six weeks later. Method of measurement: According to the color of gingiva and use of probe.</prim_outcome>
      <prim_outcome>PI Oleary was measured. Timepoint: Baseline visit and six weeks later. Method of measurement: By disclosing tablet.</prim_outcome>
      <prim_outcome>Before scaling and root planning , Strict oral hygiene instructions (OHI) were instituted on all participants at the same time by the operator. Timepoint: Baseline visit and six weeks later. Method of measurement: Measured by use of Williams probe. Recession and PD recorded in all present teeth in six sites (mesio-buccal, midbuccal, disto-buccal, mesio-palatal/lingual, mid-palatal/ lingual, and disto-palatal/lingual) in each patient of both groups by the same person.disclosing tablets was used for evaluating PI in four surfaces of teeth(mesial, distal, buccal,lingual/palatal).BI lenox was measured in four sites (mesial, distal, mid buccal and mid palatal/lingual) in all present teeth.GI index evaluated in six teeth(mandibular first molar,first premolar ,central incisors and maxillary first molar ,first premolar and cetral incisors).</prim_outcome>
      <prim_outcome>BI Lenox was measured. Timepoint: Baseline visit and six weeks later. Method of measurement: By using probe.</prim_outcome>
      <prim_outcome>Attachment level was measured. Timepoint: Baseline visit and six weeks later. Method of measurement: PD+ recession.</prim_outcome>
      <prim_outcome>Recession was measured. Timepoint: Baseline visit and six weeks later. Method of measurement: By using probe.</prim_outcome>
      <prim_outcome>PD measured. Timepoint: Baseline visit and six weeks later. Method of measurement: By probing.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Shiraz University of Medical Sciences, International Branch</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2014-10-11</approval_date>
        <contact_name>Shiraz University of Medical Sciences, International Branch</contact_name>
        <contact_address>Dentistry department, Valiasr square, next to the Nader Kazemi clinic Shiraz  Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
